RPS16P9

Across TCGA pan-cancer cohorts, RPS16P9 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of RPS16P9’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS16P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS16P9 is over-expressed in tumor.

COAD, HNSC, and LUAD are the cancer types where RPS16P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS16P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.321	<.001	9	view →
HNSC	Male	All	+0.251	.001	8	view →
LUAD	All	All	+0.426	<.001	7	view →
KICH	Male	II,III,IV	+0.100	.030	3	view →
LIHC	All	All	+0.046	.007	3	view →
UCEC	All	All	+0.825	.004	2	view →
READ	Male	All	+0.330	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

RPS16P9–COAD

Open the COAD breakdown →